Protease inhibitors do not affect antibody responses to pneumococcal vaccination

Indhira De La Rosa, Iona M. Munjal, Maria Rodriguez-Barradas, Xiaoying Yu, Liise Anne Pirofski, Daniel Mendoza

Research output: Contribution to journalArticlepeer-review


HIV+ subjects on optimal antiretroviral therapy have persistently impaired antibody responses to pneumococcal vaccination. We explored the possibility that this effect may be due to HIV protease inhibitors (PIs). We found that in humans and mice, PIs do not affect antibody production in response to pneumococcal vaccination.

Original languageEnglish (US)
Pages (from-to)524-529
Number of pages6
JournalClinical and Vaccine Immunology
Issue number6
StatePublished - Jun 2016
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Clinical Biochemistry
  • Microbiology (medical)


Dive into the research topics of 'Protease inhibitors do not affect antibody responses to pneumococcal vaccination'. Together they form a unique fingerprint.

Cite this